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Abstract 
BACKGROUND: Dermal fillers are widely used for facial and body contouring. Polymethylmethacrylate (PMMA) 
is a permanent biphasic filler for soft tissue augmentation. In case of unwanted side effects, drug therapy and 
surgical excision have been commonly used with mixed results. 
AIM: We report on a series of patients with adverse events to PMMA and an innovative minor invasive procedure 
to reduce disfigurement by nodules and lumps.  
METHODS: We employed a subdermal, intralesional 1,064 nm neodymium-doped yttrium aluminium garnet (Nd: 
YAG) laser in combination with suction using a blunt liposuction cannula of 2.0-2.5 mm of diameter. 
RESULTS: For 12 years, a total of 81 consecutive subjects (79 females and 2 males) were treated. The average 
age of the patients was 43.7 years (range 26 to 76 years). Granulomas and lumps could be removed in a minor 
invasive procedure with tumescent anaesthesia. In a minority of cases, the procedure had to be repeated. The 
results were impressive and not adverse events related to intralesional laser therapy were observed, 86.4% of 
patients were satisfied.  
CONCLUSION: The procedure should be used before or in combination with classical surgery to remove PMMA 
in case of adverse tissue reactions to PMMA. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Dermal or soft tissue fillers are versatile tools 
for correction of wrinkles, loss of volume and facial 
sagging. A broad range of filler materials is available 
from biodegradable to permanent products [1] [2]. 
Polymethylmethacrylate (PMMA) is a hydrophobic 
permanent biphasic filler for soft tissue augmentation. 
PMMA microspheres are suspended in either collagen 
(like in ArteFill or Artecoll) or methylcellulose (like 
in MetaCrill) [3]. PMMA (Bellafill) is the only FDA-
approved filler for the correction of atrophic acne 
scars [4] [5]. PMMA injections have become a fashion 
in Brazil and other Latin American countries during 
recent years, and various adverse events have been 
noted. 
Filler injections complications have been 
classified as early (0–14 days), late (14 days to 1 
year), or delayed (> 1 year) [6]. PMMA implants have 
the potential to elicit a cellular immune response in 
humans, although the mechanism of the late and 
ongoing inflammation, granuloma formation or 
nodules is not well understood [7]. One factor 
contributing to adverse events is the type and 
localisation of injection. In an animal study, 
submucosal injections were prone to nodularity in 
contrast to subcutaneous injections [8]. In humans, 
granulomatous reactions to PMMA are well-known. 
Other factors that are being discussed include 
infections, foreign body formation, and biofilms [7] [9] 
[10]. 
Early adverse events after PMMA injections 
include erythema, swelling and itching. PMMA has 
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been reported to cause in particular delayed and late 
adverse effect. In a study from Goiás, Brazil, the 
authors identified 11 cases of complications of PMMA 
injections to the midface which started from two to 24 
months after the injection. Oedema, erythema, and 
contour irregularity were seen in 100% of patients, 
followed by nodules (64%), yellowish xanthomatous 
pigmentations (36%), and eyelid malposition (18%). 
Histopathology demonstrated an ongoing 
inflammation with giant cells. Corticosteroid injection 
was of minimal effect. Surgical removal was 
performed in 82% of cases and resulted in an 
improvement of oedema, erythema, and nodules [11]. 
Salles et al., [12] observed 32 complications during 15 
years of PMMA injections for soft tissue 
augmentation. They reported acute tissue necrosis (n 
= 5), delayed granulomas (n = 10), and late chronic 
inflammatory reactions (n = 10). Lymphedema of the 
lips was noted in 6 patients, and infection was seen in 
a single patient [12]. The most severe adverse events 
observed with PMMA are extended soft tissue 
necrosis and blindness due to unintended 
intravascular injection [13] [14].  
Many treatments were suggested to improve 
these symptoms including corticosteroids and other 
drugs injections, open surgeries, suctions etc. Each 
adverse event requires a specific treatment or a 
combination of more than one approach. Acute 
infections warrant an adequate and specific antibiosis. 
Culture - if it possible - is mandatory. Granulomatous 
and inflammatory reactions can be treated with 
injections of steroids. However, the response is 
usually very poor. Side effects using steroids injection 
are very frequent including neovascular formation and 
subcutaneous adipose tissue atrophy. 5-Fluoracil also 
represents an alternative injection treatment for 
granuloma reaction. Oral allopurinol is occasionally 
employed for the treatment of inflammatory reaction. 
In our experience, the response was also very poor or 
limited. Traditional plastic surgery is trying to remove 
some amount of PMMA what usually represents a 
challenge. Fibrosis, subcutaneous tissue scarring and 
the proximity to important vascular and nerves plexus 
can lead to catastrophic complications. Specific 
regions such as the lips, nose, glabella, buttocks, 
legs, hands and penis are probably the most difficult 
areas to be treated [11] [12] [15]. 
 
 
Patients and Methods 
 
We analysed patients with adverse effects to 
polymethylmethacrylate (PMMA) injections in the face 
and body which had been treated between June 2006 
and July 2018 at Clinica Goldman de Cirurgia Plastica 
and Hospital Moinhos de Vento, in Porto Alegre, 
Brazil. The great majority of our patients already used 
all the above-cited treatments without result, with very 
poor improvement or event with exacerbation of the 
symptoms and deformities. 
Often the adverse events had been delayed 
or late with the first occurrence even after 10, 15 or 
more years. Adverse late events suddenly appeared 
with erythema, unevenness, dislocation or migration 
of the product, pain, inflammatory reactions, 
deformities (sometimes bizarre deformities), nodules 
and granulomas, functional limitations and others. In 
our series, longer lasting redness is a very frequent 
adverse event. For many years such cases have been 
treated (initially in the face and after in breast, 
buttocks, chest, legs) using the subdermal 1,064nm 
neodymium-doped yttrium aluminium garnet (Nd: 
YAG) laser in continuous-wave mode. The treatment 
is based on the same concept as laser-lipolysis and 
laser-assisted liposuction.  
With this procedure PMMA granulomas were 
treated by Nd: YAG laser in a total of 81 consecutive 
subjects who underwent the intralesional laser 
procedure, 79 were female and 2 male. The average 
age of the patients was 43.7 years (range 26 to 76 
years).  
All subjects underwent pre-operative 
assessment including autoimmune evaluation. All 
subjects provided informed consent. Imaging 
techniques were also employed in selected patients 
preoperatively (Figure 1). The procedures were 
performed in tumescent anaesthesia after 
subcutaneous infiltration of a solution containing 
lidocaine with vasoconstrictor and warm saline 
solution. The solution varies according to the area to 
be treated. Usually, all procedures in the face were 
made under local anaesthesia and sedation. Body 
procedures, including chest, penis, legs or buttocks 
were performed under general anaesthesia 
(intravenous anaesthesia). The laser power varied 
from 6 to 18W. 
 
Figure 1: Magnetic resonance imaging demonstrating intense 
contrast impregnation in the mandibular region and pterygoid 
muscle (PMMA) 
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The laser energy is delivered to the affected 
tissue through a 300-600-micron fibre optic, 
embedded in a 1 or 1.6 mm diameter stainless steel 
micro-cannula of variable length. The distal portion of 
the fibre optic is extended approximately 2 mm 
beyond the distal end of the cannula allowing the 
direct contact of the laser energy with the organic 
tissue and synthetic material/granuloma. The helium-
neon (He: Ne) laser source is combined into the laser 
beam allowing a precise visualisation of the region 
where the energy is acting, due to cutaneous trans-
illumination (Figure 2).  
 
Figure 2: Granuloma in the malar region due to PMMA injection. 
Treatment by intralesional Nd: YAG laser 
 
The cannula is moved intralesional within the 
tissue. The external skin temperature is controlled 
using a digital thermometer. The upper limit of skin 
temperature is 42
o
 Celsius to avoid a potential skin 
burn. In some subjects, a thermal camera was used at 
the same time as the laser action, which provides an 
accurate and instantaneously skin and tissue 
temperature control. Cold compresses were applied in 
the treated laser region to maintain skin integrity and 
avoid skin damage. Laser treatment is delivered over 
a variable length of time according to the amount of 
granuloma, facial or body location, previous 
treatments, external scar, internal fibrosis and 
resistance.  
 
Figure 3: a Typical aspect of aspirated PMMA material after laser 
action 
 The main concept and aim of the internal 
laser treatment are to produce tunnels in the affected 
region and to disrupt the synthetic alloplastic filler 
facilitating the suction or its surgical excision. 
Usually, the endpoint for the laser action is 
the temperature and mainly the resistance during 
cannula advancement in the fibrous tissue. The 
product of the laser action is removed using the 
negative pressure of around 450 mm Hg in 
conjunction with suction using a blunt liposuction 
cannula of 2.0-2.5 mm of diameter. The quantity of 
material removed from the patient varies according to 
each situation (Figure 3). The procedure lasts from 30 
minutes to 3 hours. 
 
Figure 4: Before (a) and after (b) intralesional Nd: YAG laser 
therapy of PMMA-induced nodule on the mandibular margin 
 
We have observed patients with a very small 
quantity of PMMA in the face but severe 
complications. At the same time, patients with a larger 
quantity of injected PMMA in the chest/breasts had no 
inflammatory problems, foreign body granulomas or 
other clinical manifestations after long years. Probably 
there is no relationship between the amount of 
removed material using laser and the clinical 
improvement as well. Many patients with very small 
PMMA volume injections in the face had an 
impressive clinical and aesthetic improvement after 
laser therapy (Figures 4, 5 and 6). 
 
Figure 5: PMMA nodule of the nasal dorsum (a); After treatment 
with an intralesional laser (b) 
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Histological studies were performed in all 
subjects, focusing on the effects of the laser. The 
laser produces channels along the fatty tissue and 
fibrous tissue including the granulomas and the 
alloplastic filler material (Figure 7). 
 
Figure 6: a Typical aspect of a patient with problems related to 
PMMA injection; (a) Plethoric face, inflammatory aspect, 
granulomas, deformities and some neovascular formations; (b) 
Result after intralesional laser treatment on the mandibular border, 
the malar and zygomatic region 
 
The procedure had to be repeated twice in 
8.6%, three times (4.9%), and four times (1.2%; chest 
and buttocks) for optimum results. Complications 
included four cases of late seroma. All solved with 
serial aspiration. No case of infection, burn or necrosis 
was observed. Transient unilateral temporary paresis 
of nerve branches was observed in 7 subjects. The 
paresis disappeared completely during a period of 3 
weeks to 3 months.  
 
Figure 7: Histology demonstrates spherical particles of exogenous 
material morphologically compatible with PMMA surrounded by 
foreign body type granulomas, lymphocytic infiltrates and 
connective tissue with hyalinization (Hematoxylin-eosin, x4) 
 
Since PMMA induces tissue fibrosis, the main 
idea was to create tunnels splitting (cleavage isolating 
the product) the material and fibrosis from the muscle, 
subcutaneous tissue, fascia, skin or mucosa using the 
laser as well as trying to disrupt the methacrylate into 
small particles facilitating the suction using small 
cannulas. After the laser action, a small cannula was 
used to aspirate this material. The aspirated material 
was always sent to the pathologist. In all cases, it was 
easily possible to identify foreign body material 
(PMMA) in great quantity and practically no fibrosis or 
organic tissue around the PMMA. The quantity of 
PMMA removed without laser was much less than 
with laser energy. 
Seventy of 81 patients (86.4%) were very 
satisfied by the outcome with an important 
improvement of the deformities in the mandibular 
border, malar region, lips and other body rejoins. We 
noted a substantial improvement of the clinical 
symptoms like pain, inflammation, nodules and 
redness.  
Some of the patients suffered from other 
extra-cutaneous complaints such as hypercalcemia 
and renal dysfunction (creatine elevation). These 
patients had PMMA in the breast, chest (male 
patient), and buttocks. All patients were submitted to 
subdermal laser treatment. In some patients, the 
procedure was repeated some months after the prior 
surgery. All patients had important clinical 
improvement, calcium level control and improvement 
in renal function. In another words - PMMA removal 
probably improved not only face and body deformities 
but systemic clinical complications produced or 
aggravated by the presence of PMMA. 
The follow-up was up to 12 years without any 
relapse or later complications after Nd: YAG laser 
therapy.  
 
 
Discussion 
 
In case of complications caused by filler 
injections systemic drugs (e.g. corticosteroids, 
antibiotics etc.) and surgical removal of the material 
are the most widely used methods [16]. For fillers 
based on hyaluronic acid, the injection of 
hyaluronidase is an efficient option [17].  
Another possible treatment option would be 
the removal of the material by intralesional laser 
treatment. The first group using intralesional laser 
therapy to handle filler complications was Cassuto et 
al., [18]. They brought to action the 808 nm diode 
laser at 6 to 8W with a pulse duration of 500 ms to 
1000 ms. Their laser fibre had a diameter of 200 µm. 
The first twenty patients who were treated, reported a 
significant improvement of pain, tenderness, stiffness, 
and size of the nodules or granulomas [18]. The same 
group published a second paper including 219 
patients. Complete disappearance of nodules and 
lumps was observed in 62%, partial improvement in 
30% of patients [19]. 
Schalke et al., [20] combined an 810 nm 
diode laser (3-6 W) with a 1,470nm diode laser (0.6-
0.8 W) in continuous-wave mode. They used fibre 
diameters between 200 µm and 600 µm for 
intralesional treatment of nodules and granulomas in 
242 patients. In 92% of cases, they achieved an 
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improvement, in 9% a complete resolution.  
The present study is the first one, using the 
intralesional Nd-YAG laser in analogy to laser lipolysis 
with the special focus on PMMA complications [21]. 
86.4% of our patients were very satisfied. This is 
remarkable since we treated only patients wing with 
complications after PMMA injection in contrast to the 
other studies mentioned [18] [19] [20]. PMMA is more 
resistant to treatment than hyaluronic acid-fillers. With 
81 patients treated for PMMA complications, this is 
one of the largest trials. 
After puncturing the skin, a bare laser fibre is 
used to ensure a focused subdermal energy delivery. 
In this trial, the skin temperature was measured during 
laser action to prevent skin burns. It is important to 
avoid carbonisation of PMMA as well [18] [19] [20]. 
For removal of filler material, a blunt suction cannula 
with negative pressure was used in contrast to 
squeeze as suggested by others [18] [19] [20]. 
The laser energy interacts with adipose or 
connective tissue or - as in the present study - with 
PMMA. With the support of a pilot beam, the depth of 
the bare fibre can be visualised. The interaction of 
laser energy and polymer ions like PMMA can be 
described by the following formula: R + A + T = 1. The 
intensity of laser energy on the irradiated surface is I0, 
the intensity of the reflected irradiation is IR, and the 
intensity of the absorbed irradiation is coined IA. The 
intensity of the transmitted irradiation is named IT. R 
(IR/I0) is the ratio of reflection, A (IA/I0) the ratio of 
absorption, and T (IT/I0) the ratio of the transmission. 
R is higher in crystalline structures than in amorphous 
structures such as PMMA [22]. The 1,064 nm Nd: 
YAG laser has a high transmission for PMMA. During 
laser contact to the polymer surface the temperature 
increases rapidly, but after cessation of laser 
irradiation the temperature drops down beneath the 
melting point of the polymer [23]. 
The laser energy can cause fragmentation of 
PMMA by (1) charge-directed fragmentations, (2) 
charge-remote rearrangements, and (3) charge-
remote fragmentations via radical intermediates [24]. 
The Nd: YAG laser irradiation results in a shallow 
focal trough with radiating fractures [25] [26]. In a 
liquid microenvironment, microchannels can be 
produced [27]. 
We suppose that microchannels are part of 
the intralesional laser action in living tissue. Eventual 
fragmentation of the material allows its evacuation. 
The liquefaction, we and other observed, is partly due 
to laser lipolysis. 
Intralesional laser therapy is a safe technique 
in the hands of experienced users. We observed 4 
cases of seroma (5%) after the procedure. Burning, 
post-inflammatory hyperpigmentation, and scarring 
could be avoided by skin temperature monitoring. We 
have not observed sterile abscess formation in 
contrast to other studies [18] [19] [20]. Transient minor 
impairment of facial nerves disappeared completely 
without intervention. 
Our data argue for significantly improved 
removal of PMMA in subcutaneous tissue by Nd: YAG 
intralesional laser application. The procedure - if 
necessary - can be repeated.  
Patients with adverse reactions to PMMA 
injection usually feel very insecure and depressed 
[28]. There is not a single definitive, safe and efficient 
treatment for all cases. Because of this, patients need 
to be informed regarding the limitation and 
expectation of each treatment. The necessity or 
convenience of retreatment using this intralesional 
laser treatment or even a combined approach must be 
discussed. It is important to be very clear about the 
fact that it is usually impossible to remove PMMA 
completely from the body or face. Clinical and 
immunologic associated problems such as 
hypercalcemia, lupus or rheumatic problems must 
also be treated. An interdisciplinary team, including 
dermatologist, plastic surgeon, rheumatologist, 
psychiatrist and other specialists, can lead to an 
improved and more effective global treatment. 
Although the intralesional Nd: YAG laser treatment 
has been shown to be effective and safe in this series, 
further studies are necessary to improve and clarify 
the utility of this technique. 
Esthetic filler injections become increasingly 
popular. Those who perform injections of fillers need 
to know about potential adverse events, their 
prevention and treatment. The efficacy and favourable 
safety profile of intralesional laser treatment to treat 
PMMA-related complications suggest the use of this 
method before or in combination to classic surgery. 
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